209959-22-8

Basic information

• Product Name: 1H-Pyrazole-5-carboxamide, 1-(3-cyano-4-fluorophenyl)-N-[2'-[[(1,1-dimethylethyl)amino]sulfonyl][1,1' -biphenyl]-4-yl]-3-methyl-
• CAS NO: 209959-22-8
• Molecular Formula: C28H26FN5O3S
• Molecular Weight: 531.611
• Mol File: 209959-22-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1H-Pyrazole-5-carboxamide, 1-(3-cyano-4-fluorophenyl)-N-[2'-[[(1,1-dimethylethyl)amino]sulfonyl][1,1' -biphenyl]-4-yl]-3-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrazole-5-carboxamide, 1-(3-cyano-4-fluorophenyl)-N-[2'-[[(1,1-dimethylethyl)amino]sulfonyl][1,1' -biphenyl]-4-yl]-3-methyl-(209959-22-8)
• EPA Substance Registry System: 1H-Pyrazole-5-carboxamide, 1-(3-cyano-4-fluorophenyl)-N-[2'-[[(1,1-dimethylethyl)amino]sulfonyl][1,1' -biphenyl]-4-yl]-3-methyl-(209959-22-8)

Safety Data

• Hazardous Substances Data: 209959-22-8(Hazardous Substances Data)

Upstream product

• 161886-21-1 2-fluoro-5-hydrazinobenzonitrile 
• 53312-81-5 3-cyano-4-fluoroaniline 
• 193006-34-7 4-(2'-tert-butylaminosulfonylphenyl)aniline 
• 209959-21-7 Ethyl [1-(3-cyano-4-fluoro)phenyl]-3-methylpyrazole-5-carboxylate 

Downstream Products

• 709655-26-5 N-{2'-[(tert-butylamino)sulfonyl]-1,1'-biphenyl-4-yl}-1-(3-cyano-4-isopropylideneaminooxyphenyl)-3-methyl-1H-pyrazole-5-carboxamide 
• 218297-95-1 1-(3'-aminobenzisoxazol-5'-yl)-3-methyl-5-[(2'-aminosulfonyl-[1,1']-biphen-4-yl)aminocarbonyl]pyrazole 
• 709654-64-8 1-(3-amino-1H-indazol-5-yl)-N-{2'-[(tert-butylamino)sulfonyl]-1,1'-biphenyl-4-yl}-3-methyl-1H-pyrazole-5-carboxamide 
• 709654-76-2 2-(4-amino-quinazolin-6-yl)-5-methyl-2H-pyrazole-3-carboxylic acid (2'-tert-butylsulfamoyl-biphenyl-4-yl)-amide 

Relevant articles and documents

Structure-based design of novel guanidine/benzamidine mimics: Potent and orally bioavailable factor Xa inhibitors as novel anticoagulants

As part of an ongoing effort to prepare orally active factor Xa inhibitors using structure-based drug design techniques and molecular recognition principles, a systematic study has been performed on the pharmacokinetic profile resulting from replacing the